Samar S Azab Selected Research

Chemotherapy-Related Cognitive Impairment

1/2022	The diuretic amiloride attenuates doxorubicin-induced chemobrain in rats: Behavioral and mechanistic study.
1/2021	Role of inflammatory, oxidative, and ER stress signaling in the neuroprotective effect of atorvastatin against doxorubicin-induced cognitive impairment in rats.
10/2020	Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis.
1/2020	Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab: Insights to neuroimmune mechanistic hallmarks.
1/2019	Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain.
7/2018	Astaxanthin Ameliorates Doxorubicin-Induced Cognitive Impairment (Chemobrain) in Experimental Rat Model: Impact on Oxidative, Inflammatory, and Apoptotic Machineries.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Samar S Azab Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 10/2008
7	Cognitive Dysfunction 02/2022 - 07/2018
6	Chemotherapy-Related Cognitive Impairment 01/2022 - 07/2018
5	Inflammation (Inflammations) 01/2020 - 04/2015
3	Arthritis (Polyarthritis) 05/2021 - 10/2018
3	Fibrosis (Cirrhosis) 08/2020 - 03/2018
3	Body Weight (Weight, Body) 10/2019 - 04/2015
3	Breast Neoplasms (Breast Cancer) 01/2009 - 09/2005
2	Neuroinflammatory Diseases 01/2022 - 10/2018
2	Insulin Resistance 08/2020 - 01/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 08/2020 - 03/2018
2	Necrosis 01/2020 - 01/2019
2	Rheumatoid Arthritis 10/2019 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 10/2019 - 01/2019
1	Tauopathies 02/2022
1	COVID-19 02/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 12/2021
1	Narcolepsy 10/2021
1	Asthma (Bronchial Asthma) 10/2021
1	Experimental Arthritis 05/2021
1	Type 2 Diabetes Mellitus (MODY) 08/2020
1	Gliosis 08/2020
1	Multiple Sclerosis 08/2020
1	Demyelinating Diseases (Demyelinating Disease) 08/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 12/2019
1	Cardiomegaly (Heart Hypertrophy) 12/2018

Drug/Important Bio-Agent (IBA)

9	AntioxidantsIBA 01/2021 - 04/2015
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 10/2008
4	Neuroprotective AgentsIBA 01/2022 - 01/2020
4	Methotrexate (Mexate)FDA LinkGeneric 10/2019 - 10/2016
3	NF-kappa B (NF-kB)IBA 01/2022 - 10/2018
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022 - 10/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 10/2018
2	Pharmaceutical PreparationsIBA 02/2022 - 10/2016
2	CholesterolIBA 02/2022 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 10/2016
2	CytokinesIBA 01/2021 - 08/2020
2	CollagenIBA 08/2020 - 03/2018
2	Infliximab (Remicade)FDA Link 01/2020 - 10/2019
2	CatalaseIBA 01/2020 - 01/2019
2	Superoxide DismutaseIBA 01/2020 - 01/2019
2	Testosterone (Sustanon)FDA Link 12/2019 - 10/2019
2	Caspase 3 (Caspase-3)IBA 01/2019 - 01/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2018 - 10/2016
2	Propolis (Bee Bread)IBA 03/2018 - 10/2016
2	caffeic acid phenethyl esterIBA 10/2016 - 08/2013
2	2-MethoxyestradiolIBA 01/2009 - 10/2008
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2022
1	tau Proteins (tau Protein)IBA 02/2022
1	Antidepressive Agents (Antidepressants)IBA 02/2022
1	Antihypertensive Agents (Antihypertensives)IBA 02/2022
1	DiureticsIBA 01/2022
1	Amiloride (Midamor)FDA LinkGeneric 01/2022
1	3,3',4,5'-tetrahydroxystilbeneIBA 12/2021
1	AminesIBA 10/2021
1	AlkaloidsIBA 10/2021
1	Ephedrine FDA LinkGeneric 10/2021
1	Sympathomimetics (Sympathomimetic Amines)IBA 10/2021
1	Epinephrine (Adrenaline)FDA LinkGeneric 10/2021
1	methyl palmitateIBA 05/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Heme Oxygenase-1IBA 01/2021
1	Atorvastatin (Lipitor)FDA Link 01/2021
1	Hematoxylin (Haematoxylon)IBA 08/2020
1	Streptozocin (Streptozotocin)FDA Link 08/2020
1	Sucrose (Saccharose)IBA 08/2020
1	LinagliptinIBA 08/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 08/2020
1	LipidsIBA 08/2020
1	Insulin (Novolin)FDA Link 08/2020
1	CuprizoneIBA 08/2020
1	Chelating AgentsIBA 08/2020
1	CopperIBA 08/2020
1	secukinumabIBA 08/2020
1	Glutathione (Reduced Glutathione)IBA 01/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2020
1	Malondialdehyde (Propanedial)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Captopril (Capoten)FDA LinkGeneric 12/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2019
1	Saline SolutionIBA 10/2019
1	CadmiumIBA 10/2019
1	Therapeutic UsesIBA 10/2019
1	Liraglutide FDA Link 10/2019
1	RamucirumabIBA 10/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 12/2018
1	blueberry extractIBA 12/2018
1	Anticonvulsants (Antiepileptic Drugs)IBA 10/2018
1	LithiumIBA 10/2018

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 01/2022 - 10/2016
3	Therapeutics 01/2022 - 10/2008
1	Obesity Management 10/2021